Cargando…
The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers
The synthesis and engineering of nanomaterials offer more robust systems for the treatment of cancer, with technologies that combine therapy with imaging diagnostic tools in the so-called nanotheranostics. Among the most studied systems, there are quantum dots, liposomes, polymeric nanoparticles, in...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539690/ https://www.ncbi.nlm.nih.gov/pubmed/34685018 http://dx.doi.org/10.3390/nano11102579 |
_version_ | 1784588808228962304 |
---|---|
author | Freitas, Lucas F. Ferreira, Aryel H. Thipe, Velaphi C. Varca, Gustavo H. C. Lima, Caroline S. A. Batista, Jorge G. S. Riello, Fabiane N. Nogueira, Kamila Cruz, Cassia P. C. Mendes, Giovanna O. A. Rodrigues, Adriana S. Sousa, Thayna S. Alves, Victoria M. Lugão, Ademar B. |
author_facet | Freitas, Lucas F. Ferreira, Aryel H. Thipe, Velaphi C. Varca, Gustavo H. C. Lima, Caroline S. A. Batista, Jorge G. S. Riello, Fabiane N. Nogueira, Kamila Cruz, Cassia P. C. Mendes, Giovanna O. A. Rodrigues, Adriana S. Sousa, Thayna S. Alves, Victoria M. Lugão, Ademar B. |
author_sort | Freitas, Lucas F. |
collection | PubMed |
description | The synthesis and engineering of nanomaterials offer more robust systems for the treatment of cancer, with technologies that combine therapy with imaging diagnostic tools in the so-called nanotheranostics. Among the most studied systems, there are quantum dots, liposomes, polymeric nanoparticles, inorganic nanoparticles, magnetic nanoparticles, dendrimers, and gold nanoparticles. Most of the advantages of nanomaterials over the classic anticancer therapies come from their optimal size, which prevents the elimination by the kidneys and enhances their permeation in the tumor due to the abnormal blood vessels present in cancer tissues. Furthermore, the drug delivery and the contrast efficiency for imaging are enhanced, especially due to the increased surface area and the selective accumulation in the desired tissues. This property leads to the reduced drug dose necessary to exert the desired effect and for a longer action within the tumor. Finally, they are made so that there is no degradation into toxic byproducts and have a lower immune response triggering. In this article, we intend to review and discuss the state-of-the-art regarding the use of nanomaterials as therapeutic and diagnostic tools for lung, breast, and prostate cancer, as they are among the most prevalent worldwide. |
format | Online Article Text |
id | pubmed-8539690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85396902021-10-24 The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers Freitas, Lucas F. Ferreira, Aryel H. Thipe, Velaphi C. Varca, Gustavo H. C. Lima, Caroline S. A. Batista, Jorge G. S. Riello, Fabiane N. Nogueira, Kamila Cruz, Cassia P. C. Mendes, Giovanna O. A. Rodrigues, Adriana S. Sousa, Thayna S. Alves, Victoria M. Lugão, Ademar B. Nanomaterials (Basel) Review The synthesis and engineering of nanomaterials offer more robust systems for the treatment of cancer, with technologies that combine therapy with imaging diagnostic tools in the so-called nanotheranostics. Among the most studied systems, there are quantum dots, liposomes, polymeric nanoparticles, inorganic nanoparticles, magnetic nanoparticles, dendrimers, and gold nanoparticles. Most of the advantages of nanomaterials over the classic anticancer therapies come from their optimal size, which prevents the elimination by the kidneys and enhances their permeation in the tumor due to the abnormal blood vessels present in cancer tissues. Furthermore, the drug delivery and the contrast efficiency for imaging are enhanced, especially due to the increased surface area and the selective accumulation in the desired tissues. This property leads to the reduced drug dose necessary to exert the desired effect and for a longer action within the tumor. Finally, they are made so that there is no degradation into toxic byproducts and have a lower immune response triggering. In this article, we intend to review and discuss the state-of-the-art regarding the use of nanomaterials as therapeutic and diagnostic tools for lung, breast, and prostate cancer, as they are among the most prevalent worldwide. MDPI 2021-09-30 /pmc/articles/PMC8539690/ /pubmed/34685018 http://dx.doi.org/10.3390/nano11102579 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Freitas, Lucas F. Ferreira, Aryel H. Thipe, Velaphi C. Varca, Gustavo H. C. Lima, Caroline S. A. Batista, Jorge G. S. Riello, Fabiane N. Nogueira, Kamila Cruz, Cassia P. C. Mendes, Giovanna O. A. Rodrigues, Adriana S. Sousa, Thayna S. Alves, Victoria M. Lugão, Ademar B. The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers |
title | The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers |
title_full | The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers |
title_fullStr | The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers |
title_full_unstemmed | The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers |
title_short | The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers |
title_sort | state of the art of theranostic nanomaterials for lung, breast, and prostate cancers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539690/ https://www.ncbi.nlm.nih.gov/pubmed/34685018 http://dx.doi.org/10.3390/nano11102579 |
work_keys_str_mv | AT freitaslucasf thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT ferreiraaryelh thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT thipevelaphic thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT varcagustavohc thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT limacarolinesa thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT batistajorgegs thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT riellofabianen thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT nogueirakamila thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT cruzcassiapc thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT mendesgiovannaoa thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT rodriguesadrianas thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT sousathaynas thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT alvesvictoriam thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT lugaoademarb thestateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT freitaslucasf stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT ferreiraaryelh stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT thipevelaphic stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT varcagustavohc stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT limacarolinesa stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT batistajorgegs stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT riellofabianen stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT nogueirakamila stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT cruzcassiapc stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT mendesgiovannaoa stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT rodriguesadrianas stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT sousathaynas stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT alvesvictoriam stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers AT lugaoademarb stateoftheartoftheranosticnanomaterialsforlungbreastandprostatecancers |